‌Treatment and recurrence of vaginal candidiasis after oral and intravaginal treatment

Authors

M Khorsandi, M Modares Gilani,*, AR Khosravi
*Corresponding Author: Email: [email protected]

Journal of Inflammatory Diseases:Vol. 4, issue 2; 25-29
Published online:Sep 30, 2000
Article type:Research Article
How to Cite:Khorsandi M, Modares Gilani M, Khosravi A. ‌Treatment and recurrence of vaginal candidiasis after oral and intravaginal treatment. J Inflamm Dis. 2024;4(2):e154708. doi:

Abstract

Abstract Background: Candida vaginit is one of the most common causes of vaginal discharge. Longterm and unsystematic treatment results in incomplete treatment and recurrent disease. Objective: To evaluate the degree of treatment and recurrence of disease after oral and intravaginal treatment. Methods: The study was conducted on 65 women having vaginal candidiasis. The subjects were randomly divided into 2 groups in which 32 cases received a single oral dose 150 mg of fluconazole and 33 women 200 mg of intravaginal clotrimazole given daily for 3 consecutive days. Favorable clinical response of both groups was measured by Z-test. Findings: No significant difference was observed in favorable clinical response of both groups after one-week treatment. The degree of recurrence of disease in fluconazole and clotrimazole group was 6.9% and 9.7% respectively in which Z-test provided no significant difference in manifestation of symptoms one week and one month after the treatment. Conclusion: The findings indicated the similar effect of oral fluconazole therapy as well as clotrimazole vaginal tablets however, further research is recommended to investigate the recurrence of disease after oral fluconazole therapy.

Copyright

© 2024, Journal of Inflammatory Diseases. This open-access article is available under the Creative Commons Attribution-NonCommercial 4.0 (CC BY-NC 4.0) International License (https://creativecommons.org/licenses/by-nc/4.0/), which allows for the copying and redistribution of the material only for noncommercial purposes, provided that the original work is properly cited.

Similar Articles

31
Jan
2007

Vaginal azoles Versus oral Fluconazole in Treatment of Recurrent Vulvovaginal Candidiasis

Zahra Fardyazar,
Shahram Habibzadeh,
Sedigheh Abdollahi Fard,
Mahshid Tello

Fardyazar Z, Habibzadeh S, Abdollahi Fard S, Tello M. Vaginal azoles Versus oral Fluconazole in Treatment of Recurrent Vulvovaginal Candidiasis. Arch Clin Infect Dis. 2007;2(1):. doi:

19
Dec
2002

Comparing Fluconazole and Clotrimazole in treatment of candida albicans vaginitis

NS Karimaan,
Z Shafaaii,
M Afraakhte,
N Valaaii,
M Ahmadi

Karimaan N, Shafaaii Z, Afraakhte M, Valaaii N, Ahmadi M. Comparing Fluconazole and Clotrimazole in treatment of candida albicans vaginitis. J Kermanshah Univ Med Sci. 2002;6(3):e81013. doi:

20
Nov
2010

Effectiveness of Fluconazole for Suppressive Maintenance Therapy in Patients with RVVC: a Randomized Placebo-Controlled Study

Forouzan Bolouri,
Nasrin Moghadami Tabrizi,
Fatemeh Davari Tanha,
Azra Azmoodeh,
Saeed Emami,
Mehraban Falahati
,et al.

Bolouri F, Moghadami Tabrizi N, Davari Tanha F, Azmoodeh A, Emami S, et al. Effectiveness of Fluconazole for Suppressive Maintenance Therapy in Patients with RVVC: a Randomized Placebo-Controlled Study. Iran J Pharm Res. 2022;8(4):e128654. doi: https://doi.org/10.22037/ijpr.2010.827

9
Sep
2012

Sensitivity of Vaginal Isolates of Candida to Eight Antifungal Drugs Isolated From Ahvaz, Iran

Zahra Salehei,
Zahra Seifi,
Ali Mahmoudabadi

Salehei Z, Seifi Z, Mahmoudabadi A. Sensitivity of Vaginal Isolates of Candida to Eight Antifungal Drugs Isolated From Ahvaz, Iran. Jundishapur J Microbiol. 2012;5(4):574-577. doi: https://doi.org/10.5812/jjm.4556

28
Jun
2021
Azole Antifungal Resistance in Candida albicans and Candida glabrata Isolated from Vulvovaginal Candidiasis Patients

Azole Antifungal Resistance in Candida albicans and Candida glabrata Isolated from Vulvovaginal Candidiasis Patients

Niloofar Deravi,
Mobina Fathi,
Seyede Nadia Tabatabaeifar,
Parichehr Pooransari,
Bahram Ahmadi,
Gholamreza Shokoohi
,et al.

Deravi N, Fathi M, Tabatabaeifar SN, Pooransari P, Ahmadi B, et al. Azole Antifungal Resistance in Candida albicans and Candida glabrata Isolated from Vulvovaginal Candidiasis Patients. Arch Clin Infect Dis. 2021;16(2):e106360. doi: https://doi.org/10.5812/archcid.106360

More by these authors

M KhorsandiPubMedScholar
M Modares GilaniPubMedScholar
AR KhosraviPubMedScholar
Share
Cited by
Metrics